1. Home
  2. VALN vs MCB Comparison

VALN vs MCB Comparison

Compare VALN & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • MCB
  • Stock Information
  • Founded
  • VALN 2012
  • MCB 1999
  • Country
  • VALN France
  • MCB United States
  • Employees
  • VALN N/A
  • MCB N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • MCB Major Banks
  • Sector
  • VALN Health Care
  • MCB Finance
  • Exchange
  • VALN Nasdaq
  • MCB Nasdaq
  • Market Cap
  • VALN 777.9M
  • MCB 694.8M
  • IPO Year
  • VALN 2021
  • MCB 2017
  • Fundamental
  • Price
  • VALN $8.94
  • MCB $77.46
  • Analyst Decision
  • VALN Strong Buy
  • MCB Buy
  • Analyst Count
  • VALN 4
  • MCB 2
  • Target Price
  • VALN $15.75
  • MCB $84.50
  • AVG Volume (30 Days)
  • VALN 129.1K
  • MCB 72.2K
  • Earning Date
  • VALN 11-06-2025
  • MCB 10-16-2025
  • Dividend Yield
  • VALN N/A
  • MCB 0.77%
  • EPS Growth
  • VALN N/A
  • MCB N/A
  • EPS
  • VALN N/A
  • MCB 6.17
  • Revenue
  • VALN $230,566,060.00
  • MCB $274,307,000.00
  • Revenue This Year
  • VALN $15.55
  • MCB $13.56
  • Revenue Next Year
  • VALN $23.93
  • MCB $11.39
  • P/E Ratio
  • VALN N/A
  • MCB $12.56
  • Revenue Growth
  • VALN 25.47
  • MCB 10.33
  • 52 Week Low
  • VALN $3.62
  • MCB $47.08
  • 52 Week High
  • VALN $12.25
  • MCB $81.33
  • Technical
  • Relative Strength Index (RSI)
  • VALN 49.28
  • MCB 54.12
  • Support Level
  • VALN $8.33
  • MCB $77.38
  • Resistance Level
  • VALN $9.46
  • MCB $80.49
  • Average True Range (ATR)
  • VALN 0.35
  • MCB 1.78
  • MACD
  • VALN -0.15
  • MCB -0.19
  • Stochastic Oscillator
  • VALN 61.30
  • MCB 27.73

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: